Safety and efficacy of COVID-19 hyperimmune globulin (HIG) solution in the treatment of active COVID-19 infection- Findings from a Prospective, Randomized, Controlled, Multi-Centric Trial

Devang Parikh, Alok Chaturvedi, Naman Shah, Piyush Patel, Ronak Patel, Suma Ray
doi: https://doi.org/10.1101/2021.07.26.21261119

Data Availability

The authors confirm that the data supporting the findings of this study are available within the article and its supplementary material.

Back to top
Posted July 27, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Safety and efficacy of COVID-19 hyperimmune globulin (HIG) solution in the treatment of active COVID-19 infection- Findings from a Prospective, Randomized, Controlled, Multi-Centric Trial
Devang Parikh, Alok Chaturvedi, Naman Shah, Piyush Patel, Ronak Patel, Suma Ray
medRxiv 2021.07.26.21261119; doi: https://doi.org/10.1101/2021.07.26.21261119
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area